DR info

臨床試験数 : 5 / 薬物数 : 6 - (DrugBank : 6) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 12

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Bosentan
   Rigshospitalet, Denmark
      2011   Phase 2   NCT01292551   Denmark;Sweden;
Dexmedetomidine
   Athena Zuppa
      2004   Phase 1   NCT00573066   -
Liothyronine I 131
   FDA Office of Orphan Products Development
      1994   Phase 1   NCT00004828   -
Methacetin Breath Test (MBT)
   Northwestern University
      2019   -   NCT04176458   United States;
Sildenafil
   Children's Hospital of Philadelphia
      2007   Phase 2   NCT00507819   United States;
Vitamin C
   University of Michigan
      2009   -   NCT00974025   United States;